GlobeNewswire Inc | Nov 12, 2021 08:00AM EST

November 12, 2021

MOUNTAIN VIEW, Calif., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, today announced the Company plans to participate in the upcoming 2021 Stifel Virtual Healthcare Conference.

David Bruce, Iridexs President and Chief Executive Officer, is scheduled to present on Tuesday, November 16, 2021, at 2:00 pm ET. Interested parties may access a live and archived webcast of the presentation at www.iridex.com.

AboutIridexIridex Corporationis a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. The Companys proprietaryMicroPulsetechnology delivers a differentiated treatment that provides safe, effective, and proven treatment for targeted sight-threatening eye conditions. Iridexs current product line is used for the treatment of glaucoma and diabetic macular edema (DME) and other retinal diseases.Iridexproducts are sold inthe United Statesthrough a direct sales force and internationally primarily through a network of independent distributors into more than 100 countries. For further information, visit theIridexwebsite at www.iridex.com.

Investor Relations ContactLeigh Salvo(415) 937-5404investors@iridex.com